278 related articles for article (PubMed ID: 34340593)
1. Predictive Value of Serum Thyroglobulin for Structural Recurrence Following Lobectomy for Papillary Thyroid Carcinoma.
Xu S; Huang H; Zhang X; Huang Y; Guan B; Qian J; Wang X; Liu S; Xu Z; Liu J
Thyroid; 2021 Sep; 31(9):1391-1399. PubMed ID: 34340593
[No Abstract] [Full Text] [Related]
2. Papillary thyroid carcinoma patients assessed to be at low or intermediary risk after primary treatment are at greater risk of long term recurrence if they are thyroglobulin antibody positive or do not have distinctly low thyroglobulin at initial assessment.
Soyluk O; Boztepe H; Aral F; Alagol F; Özbey NC
Thyroid; 2011 Dec; 21(12):1301-8. PubMed ID: 22136265
[TBL] [Abstract][Full Text] [Related]
3. Predictors of recurrence after total thyroidectomy in 1,611 patients with papillary thyroid carcinoma: postoperative stimulated serum thyroglobulin and ATA initial and dynamic risk assessment.
Ywata de Carvalho A; Kohler HF; Ywata de Carvalho CCG; Vartanian JG; Kowalski LP
Arch Endocrinol Metab; 2024 Apr; 68():e220506. PubMed ID: 38578436
[TBL] [Abstract][Full Text] [Related]
4. Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer.
Park S; Jeon MJ; Oh HS; Lee YM; Sung TY; Han M; Han JM; Kim TY; Chung KW; Kim WB; Shong YK; Kim WG
Thyroid; 2018 Aug; 28(8):997-1003. PubMed ID: 29845894
[TBL] [Abstract][Full Text] [Related]
5. Detecting Recurrence Following Lobectomy for Thyroid Cancer: Role of Thyroglobulin and Thyroglobulin Antibodies.
Ritter A; Mizrachi A; Bachar G; Vainer I; Shimon I; Hirsch D; Diker-Cohen T; Duskin-Bitan H; Robenshtok E
J Clin Endocrinol Metab; 2020 Jun; 105(6):. PubMed ID: 32219303
[TBL] [Abstract][Full Text] [Related]
6. Serum thyroglobulin testing after thyroid lobectomy in patients with 1-4 cm papillary thyroid carcinoma.
Jang A; Jin M; Kim CA; Jeon MJ; Lee YM; Sung TY; Kim TY; Kim WB; Shong YK; Kim WG
Endocrine; 2023 Aug; 81(2):290-297. PubMed ID: 36913171
[TBL] [Abstract][Full Text] [Related]
7. Is there a role for unstimulated thyroglobulin velocity in predicting recurrence in papillary thyroid carcinoma patients with detectable thyroglobulin after radioiodine ablation?
Wong H; Wong KP; Yau T; Tang V; Leung R; Chiu J; Lang BH
Ann Surg Oncol; 2012 Oct; 19(11):3479-85. PubMed ID: 22576067
[TBL] [Abstract][Full Text] [Related]
8. Predictors of thyroglobulin in the lymph nodes recurrence of papillary thyroid carcinoma undergoing total thyroidectomy.
Xing Z; Qiu Y; Li Z; Zhang L; Fei Y; Zhu J; Su A
BMC Surg; 2021 Jan; 21(1):53. PubMed ID: 33482804
[TBL] [Abstract][Full Text] [Related]
9. Clinical Impact of Detectable Antithyroglobulin Antibodies Below the Reference Limit (Borderline) in Patients with Papillary Thyroid Carcinoma with Undetectable Serum Thyroglobulin and Normal Neck Ultrasonography After Ablation: A Prospective Study.
Côrtes MCS; Rosario PW; Oliveira LFF; Calsolari MR
Thyroid; 2018 Feb; 28(2):229-235. PubMed ID: 29325506
[TBL] [Abstract][Full Text] [Related]
10. Is TSH suppression still necessary in intermediate- and high-risk papillary thyroid cancer patients with pre-ablation stimulated thyroglobulin <1 ng/mL before the first disease assessment?
Tian T; Huang R; Liu B
Endocrine; 2019 Jul; 65(1):149-154. PubMed ID: 30924085
[TBL] [Abstract][Full Text] [Related]
11. Dynamic risk stratification system in post-lobectomy low-risk and intermediate-risk papillary thyroid carcinoma patients.
Cho JW; Lee YM; Lee YH; Hong SJ; Yoon JH
Clin Endocrinol (Oxf); 2018 Jul; 89(1):100-109. PubMed ID: 29672893
[TBL] [Abstract][Full Text] [Related]
12. The utility of lymph node mapping sonogram and thyroglobulin surveillance in post thyroidectomy papillary thyroid cancer patients.
Miah CF; Zaman JA; Simon M; Davidov T; Trooskin SZ
Surgery; 2014 Dec; 156(6):1491-6; discussion 1496-7. PubMed ID: 25456939
[TBL] [Abstract][Full Text] [Related]
13. Papillary Thyroid Carcinoma Recurrence: Low Yield of Neck Ultrasound With an Undetectable Serum Thyroglobulin Level.
Epstein S; McEachern R; Khot R; Padia S; Patrie JT; Itri JN
J Ultrasound Med; 2018 Oct; 37(10):2325-2331. PubMed ID: 29498418
[TBL] [Abstract][Full Text] [Related]
14. Individualized Follow-Up Strategy for Patients with an Indeterminate Response to Initial Therapy for Papillary Thyroid Carcinoma.
Oh HS; Ahn JH; Song E; Han JM; Kim WG; Kim TY; Kim WB; Shong YK; Jeon MJ
Thyroid; 2019 Feb; 29(2):209-215. PubMed ID: 30384812
[TBL] [Abstract][Full Text] [Related]
15. Thyroglobulin level in fine-needle aspirates for preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: two different cutoff values according to serum thyroglobulin level.
Jeon MJ; Kim WG; Jang EK; Choi YM; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ; Baek JH; Lee JH; Kim TY; Shong YK; Kim WB
Thyroid; 2015 Apr; 25(4):410-6. PubMed ID: 25607926
[TBL] [Abstract][Full Text] [Related]
16. Circulating epithelial cells as potential biomarkers for detection of recurrence in patients of papillary thyroid carcinoma with positive serum anti-thyroglobulin antibody.
Li YR; Tseng CP; Hsu HL; Lin HC; Chen YA; Chen ST; Liou MJ; Lin JD
Clin Chim Acta; 2018 Feb; 477():74-80. PubMed ID: 29229463
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.
Miyauchi A; Kudo T; Miya A; Kobayashi K; Ito Y; Takamura Y; Higashiyama T; Fukushima M; Kihara M; Inoue H; Tomoda C; Yabuta T; Masuoka H
Thyroid; 2011 Jul; 21(7):707-16. PubMed ID: 21649472
[TBL] [Abstract][Full Text] [Related]
18. Prognostic Value of Pre-Ablation Stimulated Thyroglobulin in Children and Adolescents with Differentiated Thyroid Cancer.
Liu L; Zhang X; Tian T; Huang R; Liu B
Thyroid; 2020 Jul; 30(7):1017-1024. PubMed ID: 31964278
[No Abstract] [Full Text] [Related]
19. Papillary thyroid carcinomas with biochemical incomplete or indeterminate responses to initial treatment: repeat stimulated thyroglobulin assay to identify disease-free patients.
Lamartina L; Montesano T; Trulli F; Attard M; Torlontano M; Bruno R; Meringolo D; Monzani F; Tumino S; Ronga G; Maranghi M; Biffoni M; Filetti S; Durante C
Endocrine; 2016 Nov; 54(2):467-475. PubMed ID: 26668060
[TBL] [Abstract][Full Text] [Related]
20. Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
Clayman GL; Agarwal G; Edeiken BS; Waguespack SG; Roberts DB; Sherman SI
Thyroid; 2011 Dec; 21(12):1309-16. PubMed ID: 22136266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
